A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn


Contact us at to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).

Verge Genomics


We are pioneering a better drug discovery process using systems biology to improve the lives of people with neurodegenerative disorders. YC S15.

Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, we share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

Year Founded
United States of America based
$36.12 M
Field/area focus
Research papers
Therapeutic focus
  • Neuroscience
Data type
  • omics
Drug Discovery Strategy
  • Phenotypic drug discovery (PDD)
Product type
  • small molecules

Posts Mentioning This Company

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space - March 15, 2018
Biopharma Insights